이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

AFC-HD AMS Life Science 관리

관리 기준 확인 2/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	no data
CEO 소유권	n/a
경영진 평균 재임 기간	21.8yrs
이사회 평균 재임 기간	3.6yrs

최근 관리 업데이트

Recent updates

AFC-HD AMS Life Science (TSE:2927) Is Due To Pay A Dividend Of ¥15.00

Apr 17

Here's Why I Think AFC-HD AMS Life Science (TYO:2927) Might Deserve Your Attention Today

Apr 29

These 4 Measures Indicate That AFC-HD AMS Life Science (TYO:2927) Is Using Debt Safely

Apr 14

AFC-HD AMS Life Science Co., Ltd.'s (TYO:2927) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Mar 09

Is It Smart To Buy AFC-HD AMS Life Science Co., Ltd. (TYO:2927) Before It Goes Ex-Dividend?

Feb 20

The Trends At AFC-HD AMS Life Science (TYO:2927) That You Should Know About

Feb 04

Here's Why I Think AFC-HD AMS Life Science (TYO:2927) Is An Interesting Stock

Jan 17

These 4 Measures Indicate That AFC-HD AMS Life Science (TYO:2927) Is Using Debt Reasonably Well

Dec 29

AFC-HD AMS Life Science Co., Ltd. (TYO:2927) On An Uptrend: Could Fundamentals Be Driving The Stock?

Dec 02

CEO

AFC-HD AMS Life Science 에는 CEO가 없거나 그에 대한 데이터가 없습니다.

리더십 팀

이름	위치	테뉴어	보상	소유권
Nobue Hamabe	Accounting Manager & Director	21.8yrs	데이터 없음	0.17% ¥ 21.7m
Naoya Unno	GM of Technical Development Division & Director	21.8yrs	데이터 없음	0.24% ¥ 30.1m
Shigenori Fukuchi	Senior MD	18.6yrs	데이터 없음	0.29% ¥ 37.4m

21.8yrs

평균 재임 기간

55yo

평균 연령

경험이 풍부한 관리: 2927 의 관리팀은 노련하고 경험 (평균 재직 기간 21.8 년)입니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Nobue Hamabe	Accounting Manager & Director	1.6yrs	데이터 없음	0.17% ¥ 21.7m
Naoya Unno	GM of Technical Development Division & Director	20.8yrs	데이터 없음	0.24% ¥ 30.1m
Shigenori Fukuchi	Senior MD	20.8yrs	데이터 없음	0.29% ¥ 37.4m
Takehiko Asayama	Chairman	22.9yrs	JP¥234.60m	8.46% ¥ 1.1b
Hiroshi Unno	Independent Outside Director	3.6yrs	데이터 없음	0.022% ¥ 2.8m
Shigeo Minakata	Director	2.6yrs	데이터 없음	0.041% ¥ 5.2m
Shunji Sasahara	Director	3.6yrs	데이터 없음	0.036% ¥ 4.6m

3.6yrs

평균 재임 기간

55yo

평균 연령

경험이 풍부한 이사회: 2927 의 이사회는 경험(평균 재직 기간 3.6 년)으로 간주됩니다.

AFC-HD AMS Life Science 관리

관리 기준 확인 2/4

주요 정보

최근 관리 업데이트

AFC-HD AMS Life Science Co., Ltd., Annual General Meeting, Nov 28, 2023

No independent directors

AFC-HD AMS Life Science Co., Ltd., Annual General Meeting, Nov 29, 2022

No independent directors

Recent updates

AFC-HD AMS Life Science Co., Ltd. to Report Q3, 2024 Results on Jul 16, 2024

AFC-HD AMS Life Science (TSE:2927) Is Due To Pay A Dividend Of ¥15.00

First half dividend of JP¥15.00 announced

Second quarter 2024 earnings released: EPS: JP¥22.99 (vs JP¥18.05 in 2Q 2023)

AFC-HD AMS Life Science Co., Ltd. to Report Q2, 2024 Results on Apr 15, 2024

Upcoming dividend of JP¥15.00 per share

First quarter 2024 earnings released: EPS: JP¥22.76 (vs JP¥11.40 in 1Q 2023)

AFC-HD AMS Life Science Co., Ltd. to Report Q1, 2024 Results on Jan 12, 2024

Full year 2023 earnings released: EPS: JP¥77.12 (vs JP¥52.31 in FY 2022)

AFC-HD AMS Life Science Co., Ltd., Annual General Meeting, Nov 28, 2023

Upcoming dividend of JP¥15.00 per share at 3.0% yield

AFC-HD AMS Life Science Co., Ltd. to Report Fiscal Year 2023 Results on Oct 13, 2023

Third quarter 2023 earnings released: EPS: JP¥19.05 (vs JP¥16.25 in 3Q 2022)

AFC-HD AMS Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending August 31, 2023

AFC-HD AMS Life Science Co., Ltd. (TSE:2927) announces an Equity Buyback for 100,000 shares, representing 0.71% for ¥100 million.

AFC-HD AMS Life Science Co., Ltd. to Report Q3, 2023 Results on Jul 14, 2023

Second quarter 2023 earnings released: EPS: JP¥18.05 (vs JP¥10.79 in 2Q 2022)

Upcoming dividend of JP¥12.50 per share at 3.1% yield

AFC-HD AMS Life Science Co., Ltd. to Report Q2, 2023 Results on Apr 14, 2023

Investor sentiment improves as stock rises 16%

First quarter 2023 earnings released: EPS: JP¥11.40 (vs JP¥11.03 in 1Q 2022)

AFC-HD AMS Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Period Ending February 2023 and August 2023

AFC-HD AMS Life Science Co., Ltd. (TSE:2927) agreed to acquire a 51% stake in 5SPRO Joint Stock Company.

Full year 2022 earnings released: EPS: JP¥52.31 (vs JP¥107 in FY 2021)

AFC-HD AMS Life Science Co., Ltd. to Report Q1, 2023 Results on Jan 13, 2023

No independent directors

Full year 2022 earnings released: EPS: JP¥52.31 (vs JP¥107 in FY 2021)

AFC-HD AMS Life Science Co., Ltd., Annual General Meeting, Nov 29, 2022

AFC-HD AMS Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Period Ending February 2023 and August 2023

AFC-HD AMS Life Science Co., Ltd. to Report Fiscal Year 2022 Results on Oct 14, 2022

Upcoming dividend of JP¥15.00 per share

Third quarter 2022 earnings released: EPS: JP¥16.25 (vs JP¥45.13 in 3Q 2021)

AFC-HD AMS Life Science Co., Ltd. Provides Earnings Guidance for the Period Ending August 2022

AFC-HD AMS Life Science Co., Ltd. to Report Q3, 2022 Results on Jul 15, 2022

No independent directors

AFC-HD AMS Life Science Co., Ltd. Announces Dividend for the Second Quarter of 2022, Payable on May 16, 2022

Second quarter 2022 earnings released: EPS: JP¥10.79 (vs JP¥25.92 in 2Q 2021)

AFC-HD AMS Life Science Co., Ltd. to Report Q2, 2022 Results on Apr 14, 2022

Upcoming dividend of JP¥15.00 per share

Investor sentiment deteriorated over the past week

First quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Full year 2021 earnings released: EPS JP¥107 (vs JP¥48.07 in FY 2020)

Upcoming dividend of JP¥15.00 per share

Third quarter 2021 earnings released: EPS JP¥45.13 (vs JP¥6.33 in 3Q 2020)

AFC-HD AMS Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending August 2021

Investor sentiment improved over the past week

Here's Why I Think AFC-HD AMS Life Science (TYO:2927) Might Deserve Your Attention Today

These 4 Measures Indicate That AFC-HD AMS Life Science (TYO:2927) Is Using Debt Safely

Second quarter 2021 earnings released: EPS JP¥25.92 (vs JP¥13.58 in 2Q 2020)

AFC-HD AMS Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending August 2021

AFC-HD AMS Life Science Co., Ltd.'s (TYO:2927) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Is It Smart To Buy AFC-HD AMS Life Science Co., Ltd. (TYO:2927) Before It Goes Ex-Dividend?

New 90-day high: JP¥1,115

The Trends At AFC-HD AMS Life Science (TYO:2927) That You Should Know About

New 90-day high: JP¥1,088

Here's Why I Think AFC-HD AMS Life Science (TYO:2927) Is An Interesting Stock

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS JP¥26.88

New 90-day high: JP¥798

These 4 Measures Indicate That AFC-HD AMS Life Science (TYO:2927) Is Using Debt Reasonably Well

AFC-HD AMS Life Science Co., Ltd. (TYO:2927) On An Uptrend: Could Fundamentals Be Driving The Stock?

AFC-HD AMS Life Science Co., Ltd. Announces Year End Dividend for the Fiscal Year Ended August 31, 2020, Payable on November 26, 2020

Full year earnings released - EPS JP¥48.07

New 90-day low - JP¥674

Upcoming Dividend of JP¥10.00 Per Share

AFC-HD AMS Life Science Co., Ltd. to Report Fiscal Year 2020 Results on Oct 09, 2020

New 90-day high - JP¥705

New 90-day high - JP¥692

CEO

리더십 팀

평균 재임 기간